OverviewSuggest Edit

Citryll is a pharmaceutical company engaged in the treatment of autoimmune and other human diseases such as lupus, vasculitis, pulmonary fibrosis, rheumatoid arthritis and organ damage due to sepsis. It develops tACPA program, targeting the formation of neutrophil extracellular traps (NETs) to prevent or treat autoimmune diseases including rheumatoid arthritis.



Citryll is headquartered in
Oss, Netherlands

Location Map

Latest Updates

Employees (est.) (Oct 2020)10
Cybersecurity ratingBMore

Key People/Management at Citryll

Renato Chirivi

Renato Chirivi

Marlon Dijkshoorn

Marlon Dijkshoorn

Show more

Citryll Office Locations

Citryll has an office in Oss
Show all (1)

Citryll Financials and Metrics

Summary Metrics

Founding Date


Citryll total Funding

$39.9 m

Citryll latest funding size

$22.98 m

Time since last funding

4 months ago

Citryll investors

Citryll's latest funding round in July 2020 was reported to be $23 m. In total, Citryll has raised $39.9 m
Show all financial metrics

Citryll Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Citryll Online and Social Media Presence

Embed Graph

Citryll Blogs

Citryll Frequently Asked Questions

  • When was Citryll founded?

    Citryll was founded in 2019.

  • Who are Citryll key executives?

    Citryll's key executives are Renato Chirivi and Marlon Dijkshoorn.

  • How many employees does Citryll have?

    Citryll has 10 employees.

  • Who are Citryll competitors?

    Competitors of Citryll include Anavex, Fratagene Therapeutics and Neuro-Bio.

  • Where are Citryll offices?

    Citryll has an office in Oss.

  • How many offices does Citryll have?

    Citryll has 1 office.